StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Refinitiv Stock Report dd April 11th 2021

<< Previous

Bullboard Posts

Next >>

Comment by NewToInvesting7on Apr 12, 2021 11:03am

105 Views

Post# 32977164

RE:RE:Refinitiv Stock Report dd April 11th 2021

Well, I am a dumb fish. Last try.

NewToInvesting7 wrote: Sorry, not sure wht the screenshots are not showing up in my original post. Let me try again.

[img] [/img]

Cheers!

NewToInvesting7 wrote: The report gives SZLS an average rating of 3, but a 10 for fundamentals.

Average rating was 9 a few weeks ago. Not sure if the fundamentals have increased in rating, or remained the same.

Cheers!